Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way. Two acquisitions, a $3 million investment, and a number of pilot and partnership deals have shown clearly that the space is of interest. (MobiHealthNews is helping to put on two pharma-related events at the mHealth Summit next week -- be sure to join us if you'll be in...
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed.
Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
IBM's new health-focused venture, Watson Health, opened its headquarters in Cambridge, Massachusetts last week, amid the same kind of flurry of announcements and partnerships that marked its launch last April. A partnership with Teva Pharmaceuticals was one of the biggest headlines, but the company is also working with ICON, Boston Children's and Columbia Medical, and announced it just received a...
While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes.
According to Globes, the investment of "tens of millions of dollars" is part of a new push into digital health by Teva, which has also included...
